Please assess the completion status of the following clinical trial:

Trial Title: Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~* patients with type 2 diabetes, on metformin, age between 18-55 yrs, male or female~Exclusion Criteria:~* patients with type 1 diabetes, medically unstable, unacceptable clinical laboratory test results at screening

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): None
- PF-04937319 - Dose 1 (Type: EXPERIMENTAL): None
- PF-04937319 - Dose 2 (Type: EXPERIMENTAL): None
- PF-04937319 - Dose 3 (Type: EXPERIMENTAL): None
- PF-04937319 - Dose 4 (Type: EXPERIMENTAL): None
- Sitagliptin (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).